Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgery for vulvar cancer GYNECOLOGIC ONCOLOGY Dorney, K. M., Growdon, W. B., Clemmer, J., Rauh-Hain, J. A., Hall, T. R., Diver, E., Boruta, D., del Carmen, M. G., Goodman, A., Schorge, J. O., Horowitz, N., Clark, R. M. 2017; 144 (1): 136-139


The majority of hospital readmissions are unexpected and considered adverse events. The goal of this study was to examine the factors associated with unplanned readmission after surgery for vulvar cancer.Patient demographic, treatment, and discharge factors were collected on 363 patients with squamous cell carcinoma in situ or invasive cancer who underwent vulvectomy at our institution between January 2001 and June 2014. Clinical variables were correlated using ?(2) test and Student's t-test as appropriate for univariate analysis. Multivariate analysis was then performed.Of 363 eligible patients, 35.6% had in situ disease and 64.5% had invasive disease. Radical vulvectomy was performed in 39.1% and 23.4% underwent lymph node assessment. Seventeen patients (4.7%) were readmitted within 30days, with length of stay ranging 2 to 37days and 35% of these patients required a re-operation. On univariate analyses comorbidities, radical vulvectomy, nodal assessment, initial length of stay, and discharge to a post acute care facility (PACF) were associated with hospital readmission. On multivariate analysis, only discharge to a PACF was significantly associated with readmission (OR 6.30, CI 1.12-35.53, P=0.04). Of those who were readmitted within 30days, 29.4% had been at a PACF whereas only 6.6% of the no readmission group had been discharged to PACF (P=0.003).Readmission affected 4.7% of our population, and was associated with lengthy hospitalization and reoperation. After controlling for patient comorbidities and surgical radicality, multivariate analysis suggested that discharge to a PACF was significantly associated with risk of readmission.

View details for DOI 10.1016/j.ygyno.2016.11.009

View details for Web of Science ID 000392367000025

View details for PubMedID 27836203